MODIGENE INC has a total of 16 patent applications. Its first patent ever was published in 2007. It filed its patents most often in Republic of Korea, United States and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are AVAXIA BIOLOGICS INC, PBL BIOMEDICAL LAB and BHATNAGAR RAKESH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 3 | |
#2 | United States | 3 | |
#3 | Canada | 2 | |
#4 | Israel | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Australia | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Fima Udi Eyal | 11 |
#2 | Fares Fuad | 11 |
#3 | Fuad Fares | 2 |
#4 | Eyal Fima Udi | 2 |
#5 | Ue Udi Eyal Fima | 1 |
#6 | Fuad Fares F | 1 |
Publication | Filing date | Title |
---|---|---|
IL210641D0 | Long-acting interferons and derivatives thereof and methods thereof | |
CN102171249A | Long-acting interferons and derivatives thereof and methods thereof | |
US2009312254A1 | Long-acting polypeptides and methods of producing same | |
WO2007092252A2 | Long-acting polypeptides and methods of producing same |